Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sijing Zhou

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Oncotarget|June 21, 2016
Microrna-26b attenuates monocrotaline-induced pulmonary vascular remodeling via targeting connective tissue growth factor (CTGF) and cyclin D1 (CCND1)Ran Wang, Xing Ding, Sijing Zhou, et al.
Archives of Medical Science : AMS|April 7, 2025
Lung function and nonalcoholic fatty liver disease: a Mendelian randomization studyJiran Shen, Yue Wang, Sijing Zhou, et al.
International Journal of Clinical and Experimental Medicine|June 24, 2014
Role of Interleukin-17 in defense against pseudomonas aeruginosa infection in lungsXilin Xu, Bing Shao, Ran Wang, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 14, 2015
Effect of a single nucleotide polymorphism in miR-146a on COX-2 protein expression and lung function in smokers with chronic obstructive pulmonary diseaseRan Wang, Min Li, Sijing Zhou, et al.
Respiratory Medicine|November 8, 2025
Global, regional, and national burden of Pneumoconiosis caused by different etiologies: An update from the global burden of disease study 2021Jiran Shen, Jiling Wang, Binbin Zhang, et al.
Frontiers in Nutrition|April 14, 2025
Burden of colon and rectum cancer attributable to processed meat consumption in China, 1990-2021Zhouwei Zhan, Xiamei Chen, Jinping Zheng, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 28, 2017
Efficacy and Toxicity of Low-Dose versus Conventional-Dose Chemotherapy for Malignant Tumors: a Meta-Analysis of 6 Randomized Controlled TrialsXianhe Xie, Yupeng Wu, Shuimei Luo, et al.
Oncotarget|April 21, 2017
The correlation between programmed death-ligand 1 expression and driver gene mutations in NSCLCHaitao Yang, Huijuan Chen, Shuimei Luo, et al.
International Journal of Medical Sciences|August 29, 2022
Identification of three hub genes related to the prognosis of idiopathic pulmonary fibrosis using bioinformatics analysisEnze Wang, Yue Wang, Sijing Zhou, et al.
Cancer Management and Research|June 14, 2019
Efficacy and safety of programmed death 1 inhibitors in patients with advanced non-small cell lung cancer: a meta-analysisYi Liu, Sijing Zhou, Yongsheng Du, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Oncotarget|June 21, 2016
Microrna-26b attenuates monocrotaline-induced pulmonary vascular remodeling via targeting connective tissue growth factor (CTGF) and cyclin D1 (CCND1)Ran Wang, Xing Ding, Sijing Zhou, et al.
Archives of Medical Science : AMS|April 7, 2025
Lung function and nonalcoholic fatty liver disease: a Mendelian randomization studyJiran Shen, Yue Wang, Sijing Zhou, et al.
International Journal of Clinical and Experimental Medicine|June 24, 2014
Role of Interleukin-17 in defense against pseudomonas aeruginosa infection in lungsXilin Xu, Bing Shao, Ran Wang, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 14, 2015
Effect of a single nucleotide polymorphism in miR-146a on COX-2 protein expression and lung function in smokers with chronic obstructive pulmonary diseaseRan Wang, Min Li, Sijing Zhou, et al.
Respiratory Medicine|November 8, 2025
Global, regional, and national burden of Pneumoconiosis caused by different etiologies: An update from the global burden of disease study 2021Jiran Shen, Jiling Wang, Binbin Zhang, et al.
Frontiers in Nutrition|April 14, 2025
Burden of colon and rectum cancer attributable to processed meat consumption in China, 1990-2021Zhouwei Zhan, Xiamei Chen, Jinping Zheng, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 28, 2017
Efficacy and Toxicity of Low-Dose versus Conventional-Dose Chemotherapy for Malignant Tumors: a Meta-Analysis of 6 Randomized Controlled TrialsXianhe Xie, Yupeng Wu, Shuimei Luo, et al.
Oncotarget|April 21, 2017
The correlation between programmed death-ligand 1 expression and driver gene mutations in NSCLCHaitao Yang, Huijuan Chen, Shuimei Luo, et al.
International Journal of Medical Sciences|August 29, 2022
Identification of three hub genes related to the prognosis of idiopathic pulmonary fibrosis using bioinformatics analysisEnze Wang, Yue Wang, Sijing Zhou, et al.
Cancer Management and Research|June 14, 2019
Efficacy and safety of programmed death 1 inhibitors in patients with advanced non-small cell lung cancer: a meta-analysisYi Liu, Sijing Zhou, Yongsheng Du, et al.
Pageof 7